Health-care companies rose as earnings continued to come in strong. AbbVie shares rose after the drugmaker posted earnings ahead of Wall Street targets.

Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.

(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

The Federal Government says that local manufacturing of pharmaceuticals, vaccines, and medical devices is the sure path to ...

Novavax shares declined after a Wall Street Journal report that federal regulators are asking the company to complete an additional randomized clinical trial on its Covid-19 vaccine, according to ...

Federal regulators are asking Novavax to complete an additional randomized clinical trial on its Covid-19 vaccine after ...

Mrs Aribeana noted that local manufacturing of pharmaceuticals also presents opportunities for job creation, international ...

Federal regulators are asking Novavax to complete an additional clinical trial on its Covid-19 vaccine after previously ...

Food and Drug Administration Commissioner Marty Makary said he has no plans to change current policy to restrict access to the abortion pill mifepristone, despite a steady pressure campaign from ...

Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...